In conversation with...
A Life Sciences podcast by The Lancet Haematology
0.0 • 0 ratings
Want connect with The Lancet Haematology and email directly about potential partnerships?
Create a free accountRecent Episodes
Paolo Strati on off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy for patients with relapsed or refractory B-cell lymphoma
Published: July 1, 2025A panel of the authors on our Adverse Events Series on adverse event reporting in haematological malignancies
Published: June 13, 2025Michael Northend on early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma
Published: April 28, 2025Joanne Verweij and Romy Pothof on fetal and neonatal alloimmune thrombocytopenia
Published: March 31, 2025Helene Schoemans, Elke Stienissen, and Kathy Goris on a consulting a patient advisory board to understand unmet needs of patients with GVHD in Europe
Published: March 3, 2025Dawn Swan on air pollution and venous thromboembolism
Published: January 29, 2025Leslie Skeith on low-dose aspirin for postpartum venous thromboembolism prophylaxis
Published: January 16, 2025Neema Mayor and Caitlin Farrow on impact of patient ethnicity on haematopoeietic cell transplantation outcome in the United Kingdom
Published: December 3, 2024Lancet Haematology 10 year anniversary - meet the editors
Published: October 2, 2024Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
Published: August 22, 2024